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Background: The effects of baseline and changes in blood pressure and low density lipoprotein (LDL) cholesterol
on the carotid intima media thickness (IMT) have not been well documented.
Methods: A total of 2572 adults (mean age 53.8 years, 54.6% women) in a Taiwanese community undertook three
blood pressure and LDL cholesterol examinations over 6 years. Latent growth curve modeling was used to
investigate the effects of baseline and change in blood pressure and LDL cholesterol on IMT.
Results: Greater baseline LDL and blood pressure were associated with an increase in IMT (0.005 ± 0.002 mm per
1 mg/dL [p = 0.006] and 0.041 ± 0.004 mm mmHg [p <0.0001], respectively. Change in blood pressure was
associated with a significant increase in IMT (0.047±0.016, P = 0.004), whilst the association between change in LDL
and change in IMT was not statistically significant (0.008±0.006, P = 0.20).
Conclusions: Carotid IMT was associated with baseline blood pressure and LDL cholesterol, yet only changes of
blood pressure, not LDL cholesterol, were related to carotid IMT during the 6-year observation.
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It has been suggested that carotid intima media thick-
ness (IMT) is associated with metabolic syndrome com-
ponents. One cross-sectional study on 2268 Americans
showed that the average increase in IMT was 0.52 mm
in people with no metabolic syndrome and 0.69 mm in
people with 4 metabolic syndrome components [1].
However, the cross-sectional study design and the ana-
lysis of non-specific components provides limited evi-
dence for a causal interpretation of these associations
[1]. A randomized controlled trial which recruited more
than 19000 adults in Europe showed that a reduction in
both lipids and blood pressure decreased the risk of car-
diovascular events [2], indicating that blood pressure* Correspondence: ytlee@ntu.edu.tw
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IMT of the common carotid artery are considered use-
ful indicators of carotid atherosclerosis [3-5]. Al-Shali
and colleagues [6] found that age and hypertension were
associated with carotid IMT, whereas total cholesterol,
current smoking, diabetes, and gender were not. It is
noted that most studies have not distinguished differ-
ences in blood pressure and lipid profiles [5,7]. Evidence
on the cumulative effects of blood pressure and choles-
terol is insufficient. Some studies have shown that ca-
rotid plaque score is associated with an increased risk of
cardiovascular disease [7-11], but results from clinical
trials on the relationship between the reduction in blood
pressure and cholesterol and change in IMT are incon-
sistent [12-14]. Previous controlled trials showed that
except diuretics, blood pressure lowering medication
and statin decreased IMT modestly [15,16], whilst the
associations of blood pressure and LDL cholesterol with
carotid IMT remain unclear. It would therefore be usefultd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pressure and cholesterol measurements on IMT in lon-
gitudinal cohorts. The aim of this study is to use
repeated measurements of blood pressure and LDL
cholesterol levels over 6 years to investigate the effects
of changes in blood pressure and cholesterol on carotid
IMT among Taiwanese adults in a community cohort.
Methods
Study design and participants
Details of this cohort have been reported elsewhere [17-
19]. Briefly, the Chin-Shan Community Cardiovascular
Cohort Study (CCCC) started in 1990 by recruiting 1703
men and 1899 women of Chinese ethnicity aged 35 years
old and above from the Chin-Shan township, 30 km north
of metropolitan Taipei, Taiwan. Information about the life-
style and medical conditions were collected with question-
naires from in-person interviews every 2 years for the
initial 6 years up to 1994-1995. The validity and reprodu-
cibility of these measurements have been published previ-
ously [19]. A total of 2244 participants had complete
carotid ultrasonography measurements in 1994-1995 after
incomplete data of blood pressure, lipid (n=328), and in-
complete carotid ultrasonography (n=1030) were excluded
(Additional file 1: Table S1). The National Taiwan Univer-
sity Hospital Institutional Review Board approved the
study protocol, and the informed consent for participation
in the study was obtained from each participant.
Clinical measurements and biochemical markers
Body mass index was calculated as weight (in kilograms)
over height (in meters) squared. Blood pressure was
measured twice on the right arm supported and posi-
tioned at the level of the heart with a mercury sphygmo-
manometer, after participants were seated comfortably
for ten minutes. All participants were asked to refrain
from smoking cigarettes for at least 30 minutes and
from drinks with caffeine before examination.
Hypertension was defined according to the criteria
established by the Seventh Joint National Committee [20]:
systolic blood pressure more than or equal to 140 mmHg
or diastolic blood pressure more than or equal to 90
mmHg; or a history of taking hypertension medications.
Repeated measurements of blood pressure and lipid
profiles were collected biannually from 1990, and the
procedures for taking blood samples have been reported
elsewhere [21,22]. Briefly, all venous blood samples
drawn after a 12-hour overnight fast were immediately
refrigerated and transported within 6 hours to the Na-
tional Taiwan University Hospital. Serum samples were
then stored at -70°C before biochemical analysis of total
cholesterol, triglycerides, and high density lipoprotein
(HDL) cholesterol. Standard enzymatic tests for serum
cholesterol and triglycerides were used (Merck 14354and 14366, Germany, respectively). HDL levels were
measured in supernatants after the precipitation of spe-
cimens with a magnesium chloride phosphotungstate re-
agent (Merck 14993). LDL cholesterol concentrations
were calculated as total cholesterol minus cholesterol in
the supernatant by a precipitation method (Merck
14992) [23].
Ultrasound imaging on carotid artery measurements
The procedures for ultrasound sonography of carotid ar-
teries have been reported elsewhere [17,24], and the
recommendation from the expert recommendation was
strictly followed [25]. In brief, IMT were measured by
using a Hewlett-Packard SONO 1500 ultrasound system,
equipped with a 7.5 MHz real-time B-mode scanner.
Patients were asked to lie supinely with the neck
extended in a slightly lateral rotation. We then scanned
the carotid artery and identified the lumen of the carotid
artery beneath the surface of the neck. IMT was defined
as the distance between the front edge of the first echo-
genic line (lumen-intima interface) and the front edge of
the second line (media-adventitia interface) in the far
wall of the vessel. The same procedure was undertaken
on the other side of the neck. The measurement of
IMT was made on the ECG-gated R-wave (diastole)
phase using a semiautomated technique. Two measures
were made on each side. The measurement of IMT over
the distal 1cm of the common carotid artery was noted
[24]. The maximum IMT was defined by averaging
maximum measurements on both sides [26]. Partici-
pants’ medical status was unknown to cardiologists who
carried out the examinations. The inter-examiner correl-
ation coefficients ranged from 0.86 to 0.93, and the
intra-examiner correlation coefficients ranged from 0.70
to 0.87 for both sides of common carotid artery IMT
measurements. We excluded participants with IMT
more than 1.5 mm and those with significant plaque
formation.
Statistical analysis
Continuous variables are presented as mean and stand-
ard deviation, and categorical variables in contingency
tables. We used a linear regression model to test the
associations of repeated systolic blood pressure and LDL
with the carotid IMT. We used the diagnostic tools for
collinearity, namely the tolerance and variance inflation
factors, to evaluate the multicollinearity problem in our
model [27].
Latent growth curve modeling, a special application of
structural equation modeling (SEM), was then used to
analyze the associations between changes in LDL choles-
terol and systolic blood pressure (SBP) over the 6-year
period and final IMT. Separate non-linear latent growth
curve model analyses for LDL cholesterol and carotid
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[28]. Figure 1 shows the path diagram for the bivariate
latent growth curve model. Briefly, one part of latent
growth curve models used two latent variables to esti-
mate baseline SBP and LDL and their changes over 6
years (F1 & F2 for SBP and F3 & F4 for LDL in Figure
1). For example, in the SBP model, the three observed
SBP can be expressed as three linear regression models
of F1 and F2, and the coefficients are regression weights,
also known as factor loadings, for F1 and F2. When the
first coefficient fixed to equal 0 and third coefficientFigure 1 Path diagram for bivariate latent growth curve
modeling to estimate the effects of SBP and LDL on IMT within
the same model. The three repeated measurements of systolic
blood pressure (SBP1, SBP2, and SBP3), the three repeated
measurements of LDL cholesterol (LDL1, LDL2, and LDL3), and
carotid IMT (IMT) are in squares. F1 and F2 are the estimated
baseline SBP and overall change in SBP, respectively; and F3 and F4
the estimated baseline LDL and changes in LDL, respectively. To
simply the presentation, we did not show the residual error terms
and the correlations among the later variables in the graph. The
estimated coefficients and standard errors were shown and the
significance level <0.05 was presented as ‘*’. Footnote: the estimated
means±standard errors for F1 (SBP intercept) were 47.7±3.2, F2 (SBP
change) were 17.2±3.3, F3 (LDL intercept) were 22.1±7.6, F4 (LDL
change) were 23.6±5.4, all significance levels <0.05.fixed to unity, F1 becomes the estimated baseline SBP,
and F2 becomes the overall change in SBP. If velocity of
change in SBP is constant, we can fit a linear growth
curve model by fixing the second coefficient to equal 0.5
(because the three SBP were measured every 2 years). In
other words, latent growth curve modeling aims to esti-
mate baseline values and changes from baseline using
the observed repeated measurements. One advantage of
this approach is to reduce the number of variables in the
model and to overcome the problem with collinearity.
From a statistical point of view, latent growth curve
modeling is equivalent to multilevel modeling for longi-
tudinal data, and a non-technical introduction to latent
growth curve modeling can be found in our previous
publication [29]. We can also allow the factor loading
for intermediate measurements to be freely estimated; if
the changes in LDL or systolic blood pressure were lin-
ear, the factor loading for the intermediate measurement
would be close to 0.5. The advantages of this approach
are that a nonlinear change pattern can be estimated
without using polynomial functions, and the means or
intercept for the latent variables for changes (i.e. F2) can
be directly interpreted as the total changes from baseline
over the observation period. Age at baseline, sex, and
body mass index were adjusted as confounders.
Next, a bivariate latent growth curve model was then
constructed in which the IMT was regressed on the
baseline and changes of both LDL cholesterol and sys-
tolic blood pressure. Covariates, including age, gender,
and baseline body mass index were also included in the
final model. IMT values were multiplied by 100 to pre-
vent rounding errors in the computation. Several statis-
tics were evaluated for the overall model fit: (1) a small
chi-square value for model fit relative to the model
degrees of freedom with a P value greater than 0.05 indi-
cated that the proposed model fitted the data relatively
well; (2) a comparative fit index (CFI) greater than 0.95
indicated a good model; (3) a Root Mean Square Error
of Approximation (RMSEA) value less than 0.05 was
considered as a good model; and (4) a Standardized Root
Mean Square Residual (SRMR) less than 0.1 indicated a
good model fit [30]. All statistical analyses were per-
formed with the statistical software packages SAS ver-
sion 9.1.3 and Mplus version 5 [31].
Results
A total of 2244 adults (mean age of 54.3 years; 1238
women) were recruited into this study. Table 1 provides
a summary of three repeated measurements of blood
pressure, LDL cholesterol and carotid IMT. LDL choles-
terol decreased in later examinations, yet non-HDL
cholesterol and systolic blood pressure values increased
progressively. The prevalence rates of elevated LDL level
(>=220 mg/dL) in the study participants were 2–4% and
Table 1 Basic characteristics of three repeated
measurements of blood pressure and lipid profiles, and
carotid intima media thickness values in the study





Current smoking 751 33.5
Mean SD
Age, years 54.3 11.7
Body mass index, kg/m2 23.7 3.4
1st LDL cholesterol, mg/dL 139.8 43.8
2nd LDL cholesterol, mg/dL 123.0 43.5
3rd LDL cholesterol, mg/dL 129.9 39.4
1st Systolic BP, mmHg 125.0 20.2
2nd Systolic BP, mmHg 125.6 19.9
3rd Systolic BP, mmHg 126.0 19.4
1st HDL cholesterol, mg/dL 47.0 12.2
1st fasting glucose, mg/dL 109.8 30.6
Carotid intima media thickness, mm 0.74 0.24
Abbreviations: LDL, low density lipoprotein; HDL, high density lipoprotein; BP,
blood pressure.
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20–24%.
Using a multiple linear regression model (Table 2), we
found that age, gender and the first and second systolic
pressure was modestly associated with carotid IMT
(P <0.05). However, due to the problem with highTable 2 The estimated coefficients, standard errors, and
significance levels of repeated measurements of systolic
blood pressure and LDL-C levels for the carotid IMT
magnitude using traditional multiple linear regression
model in the study participants
Covariates Unit Estimate Standard error P
Intercept −1.76 0.58 0.003
Age +1 yr 0.086 0.004 <.0001
Gender Men vs. women 0.56 0.13 <.0001
Body mass index +1 kg/m2 −0.018 0.015 0.23
Smoking status Yes vs. no 0.316 0.135 0.019
1st HDL cholesterol +1 mg/dL −0.004 0.004 0.28
1st fasting glucose +1 mg/dL 0.002 0.002 0.18
1st Systolic BP +1 mmHg 0.009 0.003 0.007
2nd Systolic BP +1 mmHg 0.017 0.003 <.0001
3rd Systolic BP +1 mmHg 0.005 0.003 0.16
1st LDL cholesterol +1 mg/dL 0.001 0.001 0.39
2nd LDL cholesterol +1 mg/dL 0.001 0.001 0.37
3rd LDL cholesterol +1 mg/dL 0.003 0.002 0.07
Abbreviations: BP: blood pressure, LDL: low density lipoprotein.correlations amongst the explanatory variables, the three
LDL cholesterol and the third systolic blood values had
non-significant associations with the carotid IMT. The
regression diagnostic tests, including variance inflation
factors and collinearity diagnostic statistics, showed sub-
stantial collinearity among the variables.
Results from the bivariate latent growth curve model are
shown in Figure 1. The estimated factor loading for the
intermediate measurement was 1.61 for LDL cholesterol
and 0.62 for systolic blood pressure change, indicating
non-linear increases in repeated LDL cholesterol and sys-
tolic blood pressure during the observation period. In
addition, one unit increase of baseline LDL (mg/dL) and
blood pressure (mmHg) was associated with a 0.005 mm
(95% confidence interval [CI]: 0.001 to 0.009) and
0.041 mm (95% CI: 0.033 to 0.049) increase in carotid
IMT, respectively. An increase in blood pressure was sig-
nificantly associated with a modest increase in IMT (0.047
per 1 mmHg; 95% CI: 0.015 to 0.079, P = 0.004). However,
the positive association between the increase in LDL and
carotid IMT was not statistically significant (0.008 per
1 mmHg; 95% CI: -0.004 to 0.020, P = 0.20). The final
model fit the data well; the chi-square (DF = 15) value was
21.2 with the p-value as 0.13, indicating the relations
amongst the variables in the model were consistent with
(non-sig different from) the observed data.
Discussion
In this Taiwanese cohort, we found associations of ca-
rotid IMT with blood pressure and LDL cholesterol.
When their effects were taken into account simultan-
eously, the positive association between the increase in
LDL cholesterol and IMT became attenuated and non-
significant. This indicates that change in systolic blood
pressure may be a better predictor or a stronger risk fac-
tor for IMT.
The effects of blood pressure and lipids on carotid IMT
have been reported in previous studies [1,32]. In one study
based on 2268 adults who undertook health examinations,
increased numbers of metabolic risk factors were asso-
ciated with an increased IMT in different ethnic groups
[1]. Another study based on 1809 young Finnish adults
also showed that metabolic components were significantly
associated with carotid IMT, and the progress of IMT
among these young adults was related to obesity, LDL and
insulin resistance [32]. Another small study in Italy (240
healthy adults) from health checkups also showed an addi-
tive synergistic effect of metabolic components for IMT
[33]. Exploratory factor analysis was used to extract three
factors; obesity/dyslipidemia, hypertension, and hypergly-
cemia [33]. However, the specific effects of the compo-
nents were unclear in the factor analysis strategy. In
addition, these studies were cross-sectional in design,
without considering the cumulative effects of both blood
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ings from the multiple linear regression model showed
similar findings to those in the study of Al-Shali and col-
leagues [6]. In this study, we used latent growth curve
modeling to investigate the associations of both baseline
and changes in blood pressure and lipids on carotid IMT.
Change in blood pressure seems to have a stronger effect
on IMT than change in LDL cholesterol, suggesting the
effects of lipid-lowering treatment on carotid IMT regres-
sion might be small [34]. This is consistent with the find-
ings from clinical trials on lipid-lowering therapies in
which medications for reducing LDL had inconsistent
effects on IMT, as shown by numerous statin studies in-
cluding METEOR (rosuvastatin) [35], ACAPS (lovastatin)
[36], KAPS (pravastatin) [37], PLAC-II (pravastatin) [38],
BCAPS (fluvastatin) [39], FAST (pravastatin) [40], and RE-
GRESS (pravastatin) [41]. The stronger association be-
tween changes in blood pressure and IMT may be because
the hemodynamic change of blood pressure had a stron-
ger impact on carotid intima media thickness, while injur-
ies caused by LDL changes affected the carotid IMT
slowly and did not manifest during the study period. Con-
sequently, the change in IMT caused by carotid blood flow
may be an important indicator for endothelial function.
Evidence from antihypertensive clinical trials showed that
change of BP was related to the severity of carotid IMT re-
gression, and results from our observational study seem to
support the same hypothesis that carotid IMT is primarily
a mechanism of medial hypertrophy.
Evidence from randomized controlled trial data also
showed differential effects of blood pressure and choles-
terol lowering on carotid atherosclerosis. Among 508
combined hypertensive and hypercholesterolemic patients
under a randomized control trial for 2.6 years, the pro-
gression of the carotid IMT were not significant for
patients treated with fosinopril (−0.002±0.004 mm) or
those with fosinipril and prastatin (−0.002±0.004 mm)
[15]. Adding LDL cholesterol lowering drugs did not seem
to affect the change of IMT under the blood pressure low-
ering effects, which was also consistent with our findings.
Antihypertensive drugs were related to the carotid IMT
progression or regression, and the mechanism is complex.
For example, the net arterial volume expansion developed
as a decrease in carotid IMT after antihypertensive medi-
cation. Therefore, further investigation on different
mechanisms of carotid IMT progress by blood pressure
lowering drugs was warranted.
Latent growth curve modeling is a new tool to bio-
medical and epidemiological research, while it has been
widely used in the social sciences. Using software
packages for structural equation modeling, latent growth
curve modeling provides a flexible statistical framework
for the analysis of repeated measures in clinical practice
to investigate the baseline and changes of exposure tooutcomes [29,42]. The main advantage of using latent
growth curve modeling instead of traditional approaches
is that repeated measurements of multiple variables (e.g.
LDL and systolic blood pressure in this study) can be
incorporated into one single model, and their association
with a distant outcome (e.g. IMT) can then be tested.
This method has been successfully applied in psychology
and sociology [43], and could be a very useful tool for
longitudinal data analysis in medical research [44,45]. In
this study, we used latent growth curve modeling to esti-
mate the effects of baseline values and changes from
baseline on the carotid IMT. The clinical implication of
our findings was two fold: firstly, baseline blood pressure
and lipids are risk factors for carotid atherosclerosis se-
verity; and secondly, keeping optimal blood pressure
levels may be helpful for reducing carotid IMT.
Several limitations of our study should be mentioned.
First, IMT, rather than plaque status, was the outcome
for our investigation. Previous studies have shown that
the numbers of plaque were related to cardiovascular
complications [46] and events [47]. Second, we did not
include the medications for lipid and blood pressure in
our analysis because that information was not available.
Third, we did not measure mean carotid IMT in the
study participants, because our protocol was designed to
measure maximal carotid IMT values [24]. Finally, ca-
rotid IMT magnitude was measured once and we did
not estimate the progress of the IMT.
Conclusions
In conclusion, our study found that carotid IMT was
associated with baseline blood pressure and LDL choles-
terol measurements, but only changes in blood pressure,
not LDL cholesterol, were related to carotid IMT in this
Taiwanese cohort.
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